60
Views
1
CrossRef citations to date
0
Altmetric
Original Research

An Assessment of the Cost-Utility of Therapy for Psoriasis

, &
Pages 325-328 | Published online: 24 Dec 2022

References

  • BergstromKGArambulaKKimballABMedication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasisCutis2003724071114655784
  • [CMS] Centers for Medicare and Medicard Services2003 expected to mark the first slowdown in health care cost growth in six years [online]2004 Accessed 30 August 2004. URL: http://www.cms.hhs.gov/media/press/release.asp?Counter=961
  • DolanPModeling valuations for EuroQol Health StatesMed Care19973510951089366889
  • EuroQol GroupEuroQol-a new facility for the measurement of health related quality of lifeHealth Policy19901619920810109801
  • GoldMRCost Effectivenss in Health and Medicine1996New YorkOxford Univ Pr
  • GuyattGHFeenyDHPatrickDLMeasuring health related quality of lifeAnn Intern Med199311862298452328
  • JavitzHSWardMMFarberEThe direct cost of care for psoriasis and psoriatic arthritis in the United StatesJ Am Acad Dermatol2002468506012063481
  • JennerNCampbellJPlunkettACost of psoriasis: a study on the morbidity and financial effects of having psoriasis in AustraliaAus J Dermatol20024325561
  • KindPSpilkerBThe EuroQol instrument: an index of health-related quality of lifeQuality of life and pharmacoeconomics in clinical trials19962nd edPhiladelphiaLippincott-Raven Pub191201
  • LeonardiCTreating psoriasis as a T-cell mediated diseaseManaged Care2004134 Suppl Treating Psoriasis 138
  • [NPF] National Psoriasis FoundationPsoriasis statistics [online]2006 Accessed 8 May 2006. URL: http://www.psoriasis.org/about/stats/index.php
  • OpmeerBCHeydendaelVMDe BorgieCACosts of treatment in patients with moderate to severe plaque psoriasis: economic analysis in a randomized controlled comparison of methotrexate and cyclosporineArch Dermatol20041406859015210458
  • RichSJConsiderations for assessing the cost of biologic agents in the treatment of psoriasisJ Manag Care Pharm103 Suppl BS384115253689
  • RussellPSDermatology in the Oregon plan with implications for health care plans in other statesArch Dermatol1994130709128002641
  • UbelPAHirthRAChernewMEWhat is the price of life and why doesn’t it increase at the rate of inflationArch Intern Med200316316374112885677
  • WeissSCBergstromKGWeissSAQuality of life considerations in psoriasis treatmentDermatol Nurs15120123712751346
  • WeissSCKimballABLiewehrDJQuantifying the harmful effect of psoriasis on health-related quality of lifeJ Am Acad Dermatol2002475121812271293